Johnson & Johnson stock gains 2.25% after morning report

Published on 11/04/2026 at 17:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Johnson & Johnson stock moved higher in late Berlin trading on Wednesday. The price stands above the level cited in the morning report.

Late Trading Extends the Move

Late trading lifted Johnson & Johnson stock above the level cited in the morning report.
The shares traded above Tuesday's Xetra close during Wednesday's session.

Johnson & Johnson, US4781601046, Illustration mit AI erstellt.

Johnson & Johnson stock extended its move in late trading on Wednesday, November 4, 2026. The shares were quoted materially above the level cited in the morning report, creating a fresh market reference for investors.

Late Trading Extends the Move

The real-time quote of Johnson & Johnson stock showed 242.85 euros on Lang & Schwarz at 17:00 CET on Wednesday, November 4, 2026, up 2.25 percent on the previous Lang & Schwarz close and 0.89 percent above the Xetra close of Tuesday, November 3.

Compared with the 237.88-euro level cited in the latest relevant report at 08:01 CET, the quote was 2.09 percent higher. That change is separate from the intraday comparison with the previous Xetra session.

MedTech Remains the Recent Focus

The most recent company-focused coverage highlighted Johnson & Johnson's Impella research at the TCT 2026 cardiology meeting. Earlier reports pointed to further trial evidence expected in 2027, keeping the MedTech pipeline relevant for investors following the shares.

Johnson & Johnson focuses on healthcare innovation across disease prevention, treatment and cures. For investors, the stronger late-session quote improves the near-term market signal, while upcoming clinical and business updates remain important for assessing the company's outlook.